Geburtsdatum
Alter
30.12.1984 (Alter: 39)
39
(30.12.1984)
Draft
Saison 1 / #9 (CHI)
Saison 1 / #9
(CHI)
Team
Boston Celtics
Celtics
Career Earnings
451.00 Mio
6 x DYNE Champ
34 x All-Star
27 x ASG Starter
6 x MVP
5 x Finals-MVP
4 x All-Star MVP
1 x AST Champ
1 x STL Champ
Gesamt
TOT
37
24329
22808
4394
5164
1318
474
1788
8143
8143
1017
2818
1896
2464
708
1046
5312
940
481
245
130
15
18761
Schnitt
AVG
25.9
24.3
4.7
5.5
1.4
0.5
1.9
8.7
13.9
1.1
3.0
2.0
2.6
0.8
1.1
5.7
62.1%
36.1%
76.9%
25.4
13.0
6.6
3.5
0.4
20.0
63.4%
30.4
2.9
1.26
0.45
Career High
High
37
70
13
30
8
5
10
25
48
8
20
17
17
6
31
55
Gesamt
TOT
17
2807
3040
576
558
122
51
212
0
112
112
351
272
346
112
112
488
103
51
17
14
4
2671
Schnitt
AVG
27.3
29.5
5.6
5.4
1.2
0.5
2.1
11.8
19.0
1.1
3.4
2.6
3.4
1.1
1.1
4.7
62.2%
31.9%
78.6%
6.1
3.0
1.0
0.8
0.2
25.9
0.0%
35.2
0.0
0.00
0.00
Career High
High
41
53
13
12
4
3
6
25
35
5
16
12
13
5
6
32
Gesamt
TOT
1098
828
160
357
59
49
109
321
511
35
94
83
135
24
50
0
39
0
0
13
0
773
Schnitt
AVG
28.2
21.2
4.1
9.2
1.5
1.3
2.8
8.2
13.1
0.9
2.4
2.1
3.5
0.6
1.3
0.0
62.8%
37.2%
61.5%
19.8
0.0%
29.7
3.28
1.18
0.98
Season High
High
36
35
8
15
4
3
6
14
21
4
9
7
12
3
5
0
86.7%
80.0%
87.5%
35
0.0%
53.1
15.00
4.00
3.00
38
96
BOS
25.0
27.5
31.1
5.3
4.7
1.5
0.5
1.8
12.8
19.0
0.9
2.8
2.8
3.8
1.4
1.5
7.1
67.4%
31.3%
74.7%
24
24
12
3
0
25.3
43.0%
38.4
2.55
0.95
0.35
37
96
ATL
25.0
22.1
27.2
4.6
5.6
1.0
0.8
1.9
10.9
15.7
1.0
1.7
2.5
3.5
1.0
0.9
21.7
69.1%
57.7%
71.2%
15
15
7
2
0
20.9
40.2%
45.2
2.90
1.15
0.92
36
98
ATL
25.0
19.1
23.0
4.7
5.4
1.4
0.6
1.5
9.4
13.3
0.4
1.3
3.2
3.6
1.3
1.1
15.0
70.7%
27.8%
89.6%
27
27
12
5
1
17.6
40.7%
48.0
3.68
1.26
0.55
35
96
DEN
25.0
22.8
26.2
6.1
5.3
1.6
0.6
2.0
9.8
13.3
1.4
3.9
2.5
3.1
1.5
1.5
15.3
73.5%
35.5%
79.3%
28
28
19
6
0
20.6
38.1%
43.4
2.66
1.07
0.43
34
96
DEN
25.0
22.2
27.7
5.0
6.1
1.1
0.9
1.3
11.4
15.1
1.1
2.6
1.7
1.9
1.0
0.6
10.7
75.5%
40.8%
92.0%
27
27
13
2
0
19.8
40.7%
49.7
4.88
1.76
1.47
33
96
DEN
25.0
25.3
25.6
6.0
6.3
1.6
1.1
2.1
10.6
16.0
0.9
1.9
1.7
2.0
0.9
0.9
13.0
65.8%
48.1%
83.6%
27
27
14
5
1
21.0
37.7%
38.9
2.96
1.79
1.21
32
97
POR
25.0
27.8
32.4
6.6
6.4
1.4
0.6
1.9
12.7
18.4
1.1
3.6
3.7
4.3
1.2
1.3
6.6
69.3%
30.5%
86.7%
23
23
10
4
0
25.7
36.0%
42.2
3.44
1.07
0.43
31
97
LAL
25.0
26.4
33.2
6.1
6.9
1.6
0.6
2.1
13.4
20.2
1.1
3.3
3.0
3.6
0.8
1.2
5.5
66.2%
34.4%
84.5%
27
27
14
7
1
27.2
41.0%
44.4
3.32
1.34
0.47
30
97
POR
25.0
26.4
31.6
6.3
4.8
1.4
0.5
1.9
12.6
20.5
1.3
3.4
2.6
3.5
1.0
1.0
5.4
61.7%
37.0%
73.8%
24
24
14
6
0
27.2
42.0%
39.0
2.58
1.42
0.54
29
97
POR
25.0
25.9
29.8
5.6
5.5
2.0
0.5
2.7
11.9
20.5
0.8
3.1
3.5
4.2
1.0
1.6
2.4
57.9%
26.7%
82.4%
42
42
20
8
0
28.2
46.0%
35.7
2.04
1.24
0.34
28
98
BOS
25.0
27.2
27.2
8.0
11.1
2.1
0.6
1.6
10.3
15.3
1.4
3.6
2.4
3.5
1.2
1.3
11.1
67.2%
39.3%
68.6%
39
33
26
23
9
22.0
38.0%
44.3
6.98
1.61
0.45
27
98
LAC
25.0
25.5
31.9
5.6
9.2
2.2
0.3
1.9
11.4
17.3
2.2
5.4
2.6
3.6
0.5
1.1
17.5
66.0%
40.7%
72.3%
36
36
25
11
3
26.2
42.0%
47.5
4.87
1.98
0.28
26
97
LAC
25.0
25.6
40.0
4.0
8.6
1.8
0.5
2.3
14.0
18.5
2.4
6.0
4.9
5.8
0.6
1.2
21.3
75.7%
40.1%
84.4%
42
42
29
15
0
29.4
45.0%
57.7
3.72
1.52
0.42
25
97
BKN
25.0
27.2
29.3
5.3
3.4
2.3
0.4
2.5
11.3
18.8
0.8
2.7
4.3
6.3
1.4
1.6
-7.0
59.9%
30.0%
68.1%
11
11
4
2
0
26.9
29.0%
32.8
1.32
1.39
0.22
24
96
TOR
25.0
27.0
18.9
4.7
4.6
1.0
0.5
2.6
7.8
14.0
0.5
1.7
1.9
2.9
1.0
1.3
-0.2
55.8%
29.6%
65.6%
42
42
14
2
0
19.6
23.0%
21.1
1.77
0.76
0.38
23
96
TOR
25.0
28.4
17.3
4.0
4.0
1.1
0.4
2.7
6.8
12.2
0.4
1.7
2.5
3.1
1.0
2.4
-0.8
55.6%
24.5%
81.1%
29
29
6
1
0
18.0
21.0%
17.5
1.49
0.46
0.17
22
95
PHI
25.0
30.0
16.0
3.9
4.9
1.2
0.7
1.4
5.9
9.4
0.7
2.1
2.1
2.5
0.5
1.1
8.0
62.2%
34.5%
82.4%
27
0
0
14.1
0.0%
20.5
3.47
1.14
0.66
21
94
PHI
13.0
28.9
19.6
4.5
5.5
1.7
0.4
2.1
7.7
11.1
0.8
1.9
1.9
2.3
0.3
1.4
14.4
69.7%
40.7%
82.5%
28
1
0
16.1
0.0%
26.2
2.64
1.21
0.31
20
94
MIA
13.0
32.0
22.2
4.5
6.0
1.0
0.5
2.1
8.7
13.5
1.0
1.9
1.9
2.1
0.3
1.3
13.8
64.2%
53.2%
88.7%
25
22
6
2
0
18.4
0.0%
25.0
2.87
0.75
0.38
19
98
PHX
0.0
29.4
22.8
4.1
7.8
0.8
0.4
2.4
8.2
12.3
1.6
2.9
1.7
2.3
66.5%
56.5%
73.0%
16
5
0
18.6
0.0%
29.6
3.29
15
PHX
0.0
28.5
26.0
4.5
9.5
0.5
0.0
1.5
12.0
15.0
0.0
0.5
80.0%
0.0%
2
2
0
1
0
17.0
0.0%
36.1
6.33
14
97
ORL
0.0
34.0
24.0
6.8
2.0
1.3
0.3
2.3
10.3
21.0
0.3
1.5
0.0
0.0
0.0
0.0
48.8%
16.7%
4
24.8
0.0%
14.0
0.89
12
97
NOH
0.0
31.2
27.0
5.7
4.3
1.4
0.5
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
27
0.0
0.0%
8.8
11
96
NOH
0.0
24.7
19.8
4.4
3.7
1.2
0.5
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
43
0.0
0.0%
9.4
9
0
NOH
0.0
26.8
24.0
4.8
4.0
1.8
1.0
0.2
10.6
20.0
0.8
2.6
0.4
0.4
0.6
1.2
0.0
53.0%
30.8%
100.0%
5
0
0
0
0
23.0
0.0%
28.9
20.00
1.50
0.83
8
0
CLE
0.0
26.7
25.1
5.2
5.7
0.9
0.3
1.2
10.8
18.7
1.0
3.1
0.5
0.5
0.9
1.1
0.0
57.9%
32.3%
93.8%
30
0
0
1
0
23.2
0.0%
30.1
4.59
0.82
0.24
7
0
CLE
0.0
27.0
20.0
3.6
6.2
1.2
0.1
2.5
8.0
15.7
0.6
2.0
2.2
2.4
0.7
1.5
0.0
51.0%
28.4%
92.6%
40
0
0
4
0
21.2
0.0%
21.7
2.52
0.79
0.07
6
97
CLE
0.0
22.1
16.3
3.3
3.0
1.2
0.1
1.7
6.5
14.1
1.0
3.2
0.3
0.5
0.8
0.5
0.0
46.4%
31.3%
55.0%
42
0
0
0
0
19.2
0.0%
17.6
1.75
2.36
0.23
5
0
CLE
0.0
24.2
21.6
3.7
2.9
1.4
0.3
1.7
7.0
12.3
2.3
6.2
0.7
1.0
0.7
1.1
0.0
56.4%
38.1%
66.7%
43
0
0
0
0
20.6
0.0%
25.2
1.71
1.23
0.31
4
92
CLE
0.0
24.4
24.8
3.0
1.5
1.0
0.3
1.9
8.9
15.9
1.8
5.1
1.7
2.5
0.8
1.1
0.0
56.1%
34.2%
68.5%
29
0
0
0
0
24.0
0.0%
24.9
0.80
0.90
0.32
3
0
CLE
0.0
22.8
18.9
2.6
2.5
0.6
0.2
2.3
6.0
10.7
1.8
4.9
1.5
2.3
0.7
1.4
0.0
55.8%
36.9%
64.8%
38
0
0
1
0
18.9
0.0%
19.8
1.08
0.40
0.13
2
92
ORL
0.0
22.4
13.3
2.2
3.8
1.7
0.4
2.6
4.7
9.5
0.8
2.8
1.6
2.4
0.4
1.0
0.0
49.1%
28.7%
64.2%
39
0
0
0
0
16.0
0.0%
15.6
1.44
1.67
0.41
1
0
ORL
0.0
28.2
21.2
4.1
9.2
1.5
1.3
2.8
8.2
13.1
0.9
2.4
2.1
3.5
0.6
1.3
0.0
62.8%
37.2%
61.5%
39
0
0
13
0
19.8
0.0%
29.7
3.28
1.18
0.98
2005-04-14
04-14
ORL
BOS
25
33
6
4
1
1
6
14
21
1
2
2
6
0
1
0
65.2%
50.0%
33.3%
32
0.0%
34.0
0.67
1.00
1.00
2005-04-11
04-11
ORL
NYK
28
21
6
4
4
1
1
9
19
0
0
3
4
0
1
0
47.4%
--
75.0%
22
0.0%
27.2
4.00
4.00
1.00
2005-04-09
04-09
ORL
NJN
27
20
4
7
2
1
4
8
17
0
0
4
7
2
2
0
47.1%
--
57.1%
24
0.0%
21.9
1.75
1.00
0.50
2005-04-06
04-06
ORL
CLE
28
24
5
5
2
1
3
9
18
0
1
6
12
1
0
0
47.4%
0.0%
50.0%
27
0.0%
23.8
1.67
--
--
2005-04-02
04-02
ORL
IND
25
22
3
6
1
1
4
10
11
0
1
2
4
1
2
0
83.3%
0.0%
50.0%
18
0.0%
31.8
1.50
0.50
0.50
2005-04-01
04-01
ORL
CHI
27
15
7
5
4
2
3
6
10
0
1
3
4
1
0
0
54.5%
0.0%
75.0%
16
0.0%
26.9
1.67
--
--
2005-03-30
03-30
ORL
SAS
26
20
4
6
0
1
1
4
6
4
5
0
0
0
1
0
72.7%
80.0%
--
12
0.0%
32.4
6.00
0.00
1.00
2005-03-29
03-29
ORL
CHA
32
22
6
5
1
2
1
6
12
3
9
1
5
0
2
0
42.9%
33.3%
20.0%
24
0.0%
19.0
5.00
0.50
1.00
2005-03-15
03-15
ORL
MIL
26
9
4
12
1
2
3
3
8
1
2
0
0
0
1
0
40.0%
50.0%
--
13
0.0%
18.9
4.00
1.00
2.00
2005-03-15
03-15
ORL
GSW
27
19
4
8
2
1
1
6
10
1
3
4
6
2
1
0
53.8%
33.3%
66.7%
17
0.0%
31.7
8.00
2.00
1.00
2005-03-14
03-14
ORL
NJN
26
18
3
8
1
0
0
6
10
2
3
0
2
0
0
0
61.5%
66.7%
0.0%
14
0.0%
29.8
--
--
--
2005-03-09
03-09
ORL
CHA
26
8
6
7
3
1
3
4
11
0
3
0
0
3
1
0
28.6%
0.0%
--
17
0.0%
12.1
2.33
3.00
1.00
2005-03-05
03-05
ORL
MIA
28
35
4
5
2
2
1
10
14
3
4
6
8
2
0
0
72.2%
75.0%
75.0%
23
0.0%
51.5
5.00
--
--
2005-03-05
03-05
ORL
HOU
26
17
2
7
0
1
0
8
14
0
2
1
4
0
1
0
50.0%
0.0%
25.0%
18
0.0%
21.0
--
0.00
1.00
2005-03-02
03-02
ORL
MIL
27
23
6
11
0
3
0
8
11
1
3
4
6
1
2
0
64.3%
33.3%
66.7%
17
0.0%
41.8
--
0.00
1.50
2005-02-27
02-27
ORL
CHI
24
25
5
13
1
3
3
8
10
1
2
6
7
0
1
0
75.0%
50.0%
85.7%
18
0.0%
51.6
4.33
1.00
3.00
2005-02-26
02-26
ORL
DET
27
19
6
11
0
2
5
7
10
1
3
4
4
0
0
0
61.5%
33.3%
100.0%
20
0.0%
31.1
2.20
--
--
2005-02-26
02-26
ORL
DEN
27
17
2
12
0
0
4
7
12
0
2
3
6
0
3
0
50.0%
0.0%
50.0%
21
0.0%
18.1
3.00
0.00
0.00
2005-02-25
02-25
ORL
TOR
25
18
4
10
1
0
3
8
14
0
1
2
2
0
1
0
53.3%
0.0%
100.0%
19
0.0%
26.2
3.33
1.00
0.00
2005-02-20
02-20
ORL
BOS
28
19
5
15
0
0
2
8
12
0
0
3
5
1
2
0
66.7%
--
60.0%
16
0.0%
32.9
7.50
0.00
0.00
2005-02-19
02-19
ORL
SEA
27
18
8
11
2
0
2
7
15
1
2
1
2
3
0
0
47.1%
50.0%
50.0%
20
0.0%
30.4
5.50
--
--
2005-02-17
02-17
ORL
PHI
26
31
5
7
2
0
5
12
14
1
1
4
4
0
1
0
86.7%
100.0%
100.0%
22
0.0%
45.4
1.40
2.00
0.00
2005-01-30
01-30
ORL
NOH
30
21
3
6
1
2
4
10
16
0
1
1
2
1
2
0
58.8%
0.0%
50.0%
22
0.0%
21.4
1.50
0.50
1.00
2005-01-26
01-26
ORL
ATL
28
14
2
9
1
2
4
7
10
0
2
0
0
0
3
0
58.3%
0.0%
--
16
0.0%
18.2
2.25
0.33
0.67
2005-01-21
01-21
ORL
UTA
30
22
6
14
3
0
6
9
14
0
0
4
4
0
2
0
64.3%
--
100.0%
22
0.0%
31.7
2.33
1.50
0.00
2005-01-17
01-17
ORL
DAL
30
20
1
10
2
1
2
10
15
0
3
0
3
0
0
0
55.6%
0.0%
0.0%
21
0.0%
24.6
5.00
--
--
2005-01-16
01-16
ORL
IND
30
18
3
8
1
0
2
6
10
2
2
0
0
1
0
0
66.7%
100.0%
--
14
0.0%
25.7
4.00
--
--
2005-01-15
01-15
ORL
POR
27
30
4
10
3
2
1
12
17
2
3
0
0
3
1
0
70.0%
66.7%
--
21
0.0%
53.1
10.00
3.00
2.00
2005-01-09
01-09
ORL
DET
30
15
6
12
3
2
3
6
9
1
2
0
0
0
5
0
63.6%
50.0%
--
14
0.0%
27.6
4.00
0.60
0.40
2005-01-09
01-09
ORL
TOR
30
17
3
14
1
0
4
7
9
1
4
0
0
0
1
0
61.5%
25.0%
--
17
0.0%
24.8
3.50
1.00
0.00
2005-01-09
01-09
ORL
MIN
31
23
3
13
0
0
2
10
13
1
2
0
0
0
0
0
73.3%
50.0%
--
17
0.0%
33.0
6.50
--
--
2005-01-08
01-08
ORL
LAC
32
21
2
10
1
1
5
9
11
1
5
0
0
0
0
0
62.5%
20.0%
--
21
0.0%
22.8
2.00
--
--
2005-01-07
01-07
ORL
LAL
30
16
2
10
1
3
5
5
12
2
4
0
0
0
0
0
43.8%
50.0%
--
21
0.0%
17.5
2.00
--
--
2005-01-07
01-07
ORL
CLE
28
28
6
14
3
2
4
12
12
1
1
1
2
1
3
0
100.0%
100.0%
50.0%
18
0.0%
52.6
3.50
1.00
0.67
2005-01-06
01-06
ORL
PHX
29
25
2
15
1
1
1
10
13
1
3
2
6
0
1
0
68.8%
33.3%
33.3%
20
0.0%
39.8
15.00
1.00
1.00
2005-01-05
01-05
ORL
WAS
31
27
5
15
1
3
3
13
18
0
1
1
1
0
2
0
68.4%
0.0%
100.0%
22
0.0%
40.3
5.00
0.50
1.50
2005-01-05
01-05
ORL
SAC
36
34
3
3
3
3
3
11
21
2
8
6
7
1
2
0
44.8%
25.0%
85.7%
35
0.0%
25.7
1.00
1.50
1.50
2005-01-05
01-05
ORL
NYK
28
18
3
9
3
1
2
8
16
0
0
2
4
0
4
0
50.0%
--
50.0%
20
0.0%
24.0
4.50
0.75
0.25
2005-01-04
01-04
ORL
MEM
30
26
1
6
1
1
3
8
16
1
3
7
8
0
1
0
47.4%
33.3%
87.5%
26
0.0%
24.4
2.00
1.00
1.00